Join to View Full Profile
6431 Fannin St# 4.234Houston, TX 77030
Phone+1 713-500-6683
Fax+1 713-500-6699
Dr. Bishehsari is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Tehran University of Medical Sciences School of MedicineClass of 2005
Certifications & Licensure
IL State Medical License 2011 - 2026
TX State Medical License 2024 - 2025
PA State Medical License 2008 - 2011
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Gastroenterology
Clinical Trials
- Abnormal Food Timing and Circadian Dyssynchrony in Alcohol Induced Colon Carcinogenesis Start of enrollment: 2016 Jul 31
Publications & Presentations
PubMed
- Stromal fibrin shapes immune infiltration landscape of pancreatic ductal adenocarcinoma.Mazharul Karim, Md Mahedi Hasan, Seung Hyun Kim, Zulfikar Azam, Riajul Wahab
Biomaterials. 2025-09-01 - Correction: Association of late eating with colorectal adenomas: a cross-sectional study.Darbaz Adnan, Edena R Khoshaba, Mostafa K Abdel-Reheem, Jonathan Q Trinh, Yin Cao
European Journal of Nutrition. 2025-02-04 - Light-dark shift promotes colon carcinogenesis through accelerated colon aging.Deepak Sharma, Phillip A Engen, Abu Osman, Darbaz Adnan, Maliha Shaikh
Iscience. 2025-01-17
Press Mentions
Pancreatic Cancer Researcher Earns NIH HonorOctober 4th, 2022- Opioid Use Identified as Potential Pancreatic Cancer Risk FactorFebruary 16th, 2021
- 08 Jan Could Opioids Account for the Rise of Pancreatic Cancer?January 8th, 2021
- Join now to see all
Grant Support
- Impact of Circadian-Microbiome Interaction on the Gut-Pancreas Axis in AgingUNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON2024–2029
- Development of a precision medicine platform for circadian based therapeutics in pancreatic cancerUNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON2024–2027
- Personalized Organoid-Chip Model For Drug Testing in Pancreatic CancerUNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON2023–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
